TrialClinical cancer research : an official journal of the American Association for Cancer Research2014

Prognostic biomarkers in phase II trial of cetuximab-containing induction and chemoradiation in resectable HNSCC: Eastern cooperative oncology group E2303.

Amanda Psyrri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.